.png){kind=icon}
.png){kind=icon}
Return
Development of a novel xCT transporter imaging using a radiopharmaceutical with inhibitor-type compounds
.png){kind=icon}
PRE
AI
K
J
Y
Y
J
A
M
R
N
M
K
DOI：10.1016/j.nucmedbio.2026.109625.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The cystine/glutamate antiporter xCT has attracted attention due to its role in maintaining redox homeostasis. Noninvasive techniques for visualizing xCT expression in tumors provide valuable diagnostic information for evaluating tumor biology. Therefore, we developed and evaluated a novel SPECT radiopharmaceutical to visualize xCT expression in cancer cells based on inhibitors.
Keywords:
xCT transporter
radiopharmaceutical
SPECT imaging
cancer cells
inhibitor-type compounds
Journal
IF:
3
Papers:
3.7K
Citations:
3.2K
Organization
Cited Papers